Robust statistical methods for longitudinal microbiome studies
Active Project Grant Awarded Last action
- Award ID
- R01GM155734
- Recipient
-
Weill Medical College Of Cornell University UEI YNT8TCJH8FQ8
- Awarding agency
-
National Institute of General Medical Sciences
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,635,704
Award facts
- Assistance listing
- 93.859 Biomedical Research and Research Training
- Completion date 44% complete
- Place of performance
- New York, NY 10065, USA
Award details come from USAspending.gov.
Description
- Abstract
- Large-scale longitudinal microbiome studies are increasingly common as they allow investigators to study temporal patterns of the microbiome, elucidating the forces that shape the microbiome and enabling the development of microbiota-based interventions. Unfortunately, despite the potential of longitudinal microbiome studies, few methods exist for analyzing these studies. Also, the few extant tailored methods are limited, either failing to accommodate the characteristics of microbiome data or failing to properly accommodate the longitudinal structure, leading to potentially spurious findings. This proposal aims to fill the critical gaps in methodology by addressing four major areas. Specifically, we aim to develop a comprehensive and coherent suite of statistical tools for (1) addressing batch effects in longitudinal microbiome data - a pressing problem as studies are getting bigger or integrated; (2) improved identification of individual taxa associated with crucial biomedical exposures or outcomes over time; (3) identifying microbiome interaction network dynamics between taxa within longitudinal microbiome data; (4) visualizing the longitudinal microbiome data. These approaches are all based on rigorous prior data emphasizing the importance of the problems as well as the limitations or absence of existing strategies. Our work is motivated by and will directly enable analyses within three important longitudinal microbiome profiling studies: few studies have the combination of large cohorts of patients with numerous follow-UPS and rich covariates. Consequently, our methods have the potential to accelerate understanding of the roles of the microbiome in diseases and therapeutics, especially in the motivating studies that include populations of infants with diabetes and immunocompromised individuals (patients undergoing kidney or bone marrow transplant). Ultimately, the deployment of our methods could guide the design and development of novel microbiota-based preventive and therapeutic interventions.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $390,484 | |
| Amendment | $390,484 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $427,368 | |
| Original award | $427,368 |
Subawards
| Subrecipient | Amount | Awarded |
|---|---|---|
| The Johns Hopkins University | $224,980 | |
| The Trustees Of The University Of Pennsylvania | $72,893 | |
| Fred Hutchinson Cancer Research Center | $75,794 |
Quick answers
Who received award R01GM155734?
R01GM155734 was awarded to Weill Medical College Of Cornell University by National Institute of General Medical Sciences (National Institutes of Health) on September 25, 2024.
How much is award R01GM155734 worth?
$1,635,704 has been obligated on R01GM155734.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award